pentoxifylline has been researched along with Stroke in 7 studies
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effect of cilostazol on initial and absolute claudication distances, mortality and vascular events in patients with stable intermittent claudication." | 9.12 | Cilostazol for intermittent claudication. ( Brown, T; Cleanthis, M; Forster, RB; Mikhailidis, DP; Stansby, G; Stewart, M, 2021) |
| "To determine the effect of cilostazol (an antiplatelet treatment) on improving initial and absolute claudication distances, and in reducing mortality and vascular events in patients with stable intermittent claudication." | 8.90 | Cilostazol for intermittent claudication. ( Bedenis, R; Cleanthis, M; Mikhailidis, DP; Robless, P; Stansby, G; Stewart, M, 2014) |
| "To assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke." | 8.82 | Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Bath, PM; Bath-Hextall, FJ, 2004) |
| "The objective of this review was to assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke." | 8.80 | Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Asplund, K; Bath, FJ; Bath, PM, 2000) |
| "To determine the effect of cilostazol on initial and absolute claudication distances, mortality and vascular events in patients with stable intermittent claudication." | 5.12 | Cilostazol for intermittent claudication. ( Brown, T; Cleanthis, M; Forster, RB; Mikhailidis, DP; Stansby, G; Stewart, M, 2021) |
| "To determine the effect of cilostazol (an antiplatelet treatment) on improving initial and absolute claudication distances, and in reducing mortality and vascular events in patients with stable intermittent claudication." | 4.90 | Cilostazol for intermittent claudication. ( Bedenis, R; Cleanthis, M; Mikhailidis, DP; Robless, P; Stansby, G; Stewart, M, 2014) |
| "To assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke." | 4.82 | Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Bath, PM; Bath-Hextall, FJ, 2004) |
| "The objective of this review was to assess the effect of intravenous or oral methylxanthines (pentoxifylline, propentofylline, or pentifylline) in patients with acute ischaemic stroke." | 4.80 | Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. ( Asplund, K; Bath, FJ; Bath, PM, 2000) |
| "Adult Wistar-Kyoto underwent a 2-h middle cerebral artery occlusion followed by an MRI study after 3 h of reperfusion, which consisted of T2- and diffusion-weighted techniques." | 1.35 | Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. ( Candelario-Jalil, E; Estrada, EY; Rosenberg, GA; Sood, RR; Taheri, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, T | 1 |
| Forster, RB | 1 |
| Cleanthis, M | 2 |
| Mikhailidis, DP | 2 |
| Stansby, G | 2 |
| Stewart, M | 2 |
| Bedenis, R | 1 |
| Robless, P | 1 |
| Banfi, C | 1 |
| Sironi, L | 1 |
| De Simoni, G | 1 |
| Gelosa, P | 1 |
| Barcella, S | 1 |
| Perego, C | 1 |
| Gianazza, E | 1 |
| Guerrini, U | 1 |
| Tremoli, E | 1 |
| Mussoni, L | 1 |
| Bath, PM | 2 |
| Bath-Hextall, FJ | 1 |
| Sood, RR | 1 |
| Taheri, S | 1 |
| Candelario-Jalil, E | 1 |
| Estrada, EY | 1 |
| Rosenberg, GA | 1 |
| Bath, FJ | 1 |
| Asplund, K | 1 |
| Handschu, R | 1 |
| Garling, A | 1 |
| Heuschmann, PU | 1 |
| Kolominsky-Rabas, PL | 1 |
| Erbguth, F | 1 |
| Neundörfer, B | 1 |
4 reviews available for pentoxifylline and Stroke
| Article | Year |
|---|---|
Cilostazol for intermittent claudication.
Topics: Aged; Bias; Cilostazol; Humans; Intermittent Claudication; Middle Aged; Myocardial Infarction; Pento | 2021 |
Cilostazol for intermittent claudication.
Topics: Aged; Cilostazol; Humans; Intermittent Claudication; Middle Aged; Myocardial Infarction; Pentoxifyll | 2014 |
Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke.
Topics: Brain Ischemia; Humans; Neuroprotective Agents; Pentoxifylline; Platelet Aggregation Inhibitors; Str | 2004 |
Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke.
Topics: Brain Ischemia; Humans; Neuroprotective Agents; Pentoxifylline; Platelet Aggregation Inhibitors; Str | 2000 |
3 other studies available for pentoxifylline and Stroke
| Article | Year |
|---|---|
Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Inflammation; Male; Pentoxifylline; Proteinuria; Ra | 2004 |
Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain.
Topics: Animals; Benzyl Compounds; Blood-Brain Barrier; Dexamethasone; Drug Combinations; Infarction, Middle | 2008 |
Acute stroke management in the local general hospital.
Topics: Diuretics; Echocardiography; Electrocardiography; Germany; Health Resources; Hospitals, Community; H | 2001 |